Hair Loss News and Research

RSS
EC approves Plexxikon's Zelboraf to treat BRAF mutation-positive MM

EC approves Plexxikon's Zelboraf to treat BRAF mutation-positive MM

Roche’s skin cancer drug Erivedge gets FDA nod

Roche’s skin cancer drug Erivedge gets FDA nod

FDA approves Genentech's Erivedge for treatment of BCC

FDA approves Genentech's Erivedge for treatment of BCC

Genentech receives FDA approval for Erivedge to treat basal cell carcinoma

Genentech receives FDA approval for Erivedge to treat basal cell carcinoma

UHCMC now offers HITEC for women with gynecologic cancers

UHCMC now offers HITEC for women with gynecologic cancers

Researchers discover HS1.2 enhancer as the cause of SLE

Researchers discover HS1.2 enhancer as the cause of SLE

CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer

CMS assigns J-code for Eisai's Halaven Injection to treat breast cancer

FDA accepts Genentech's vismodegib NDA for review

FDA accepts Genentech's vismodegib NDA for review

Scientists pinpoint central elements of cell division

Scientists pinpoint central elements of cell division

New potential leukemia therapy targets and kills cancer cells

New potential leukemia therapy targets and kills cancer cells

Women more likely to develop lupus at earlier ages

Women more likely to develop lupus at earlier ages

HHWC medical doctors provide insight into depression

HHWC medical doctors provide insight into depression

Teriflunomide drug reduces relapse rate of people with MS

Teriflunomide drug reduces relapse rate of people with MS

Genentech announces results of trastuzumab emtansine Phase II study on HER2-positive mBC

Genentech announces results of trastuzumab emtansine Phase II study on HER2-positive mBC

Hair loss, divorce and smoking in women – links established

Hair loss, divorce and smoking in women – links established

HealthWell Foundation introduces new lupus fund

HealthWell Foundation introduces new lupus fund

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma

Scientists invent new system that uses magnetism to purify hybrid nanoparticles

Scientists invent new system that uses magnetism to purify hybrid nanoparticles

Stem cell therapy for baldness

Stem cell therapy for baldness

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.